scorecardresearch
Follow Us:
Tuesday, September 28, 2021

Covid vaccination: Near total 1-shot cover in Himachal; UP, Bengal at bottom

As on September 1, nearly 51 crore people — which is 54 per cent of the estimated 93.8 crore people above the age of 18 years in India — had received at least one dose of the vaccine. Over 15.32 crore of these individuals have received their second dose as well.

Written by Amitabh Sinha | New Delhi |
Updated: September 3, 2021 10:36:50 am
A queue for Covid-19 vaccine at a government hospital in Nadia, Bengal, the worst-performing state in vaccination. (PTI)

Seven and a half months into the national vaccination drive, India has got more than half its adult population inoculated with at least one dose of a Covid-19 vaccine.

In the two small states of Sikkim and Himachal Pradesh, and in the Union Territory of Dadra and Nagar Haveli and Daman and Diu, almost every eligible person has received at least one dose of the vaccine, data show.

As on September 1, nearly 51 crore people — which is 54 per cent of the estimated 93.8 crore people above the age of 18 years in India — had received at least one dose of the vaccine. Over 15.32 crore of these individuals have received their second dose as well.

Besides Himachal and Sikkim, Uttarakhand, Kerala, Gujarat, and Madhya Pradesh too have done well; over 70 per cent of their adult population have been administered at least one dose (see box).

In these states, over a quarter of the eligible population have been inoculated with the second dose as well.

In every state across the country, at least 40 per cent of people have received at least one vaccine dose. The lowest coverage is in West Bengal, where about 41 per cent have been immunised with a single shot. Jharkhand, Uttar Pradesh, Bihar, and Tamil Nadu have done better than West Bengal, but are still well short of the share of vaccinated people nationally. In at least eight big states, less than 50 per cent of the adult population have been vaccinated.

Over 66 crore vaccine doses have been administered until now, of which Covishield — the vaccine developed by AstraZeneca and Oxford University, and manufactured in India under licence by Pune-based Serum Institute in India — accounts for more than 87 per cent.

Nearly 12 per cent of all doses have been that of Covaxin of Bharat Biotech; the remaining 1 per cent have been those of the Russian Sputnik V.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest India News, download Indian Express App.

  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement